Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

But as AI has become more prevalent, we have started to recognise the advantages and opportunities it offers through a ...

The European Medicines Group (EMG) has appointed Sanofi’s Rippon Ubhi as its new chair. Ubhi, who will maintain her position ...

New Environmental, Social and Governance (ESG) regulations coming into force across the EU in 2025 stand to shift how ...

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and ...

Researchers led by the Institute of Cancer Research (ICR) have identified a potential new treatment approach to slow down the ...

The medical communications (med comms) industry is critical in bridging the gap between new medical innovations, healthcare ...